Suppr超能文献

输血与创伤患者的供体白细胞微嵌合体有关。

Blood transfusion is associated with donor leukocyte microchimerism in trauma patients.

作者信息

Utter Garth H, Owings John T, Lee Tzong-Hae, Paglieroni Teresa G, Reed William F, Gosselin Robert C, Holland Paul V, Busch Michael P

机构信息

Department of Surgery, University of California, Davis, Medical Center, Blood Centers of the Pacific, San Francisco, California 95817, USA.

出版信息

J Trauma. 2004 Oct;57(4):702-7; discussion 707-8. doi: 10.1097/01.ta.0000140666.15972.37.

Abstract

INTRODUCTION

Blood transfusion can result in survival of donor leukocyte subpopulations in the recipient. Persistence of donor leukocytes in the transfusion recipient is termed microchimerism. Microchimerism likely reflects engraftment of the recipient with donor hematopoietic stem cells and is very uncommon with transfusion for elective surgery, sickle cell anemia, thalassemia, and HIV. We have found, however, that microchimerism may be more common in trauma patients.

OBJECTIVE

To determine how frequently transfusion after trauma is associated with microchimerism.

METHODS

We prospectively enrolled 45 trauma patients who were transfused > or =2 units of PRBCs. We sampled blood before hospital discharge and determined microchimerism by polymerase chain reaction (PCR) analysis of specimens using quantitative allele-specific HLA DR assays to detect non-recipient alleles. Data are expressed as median with interquartile range.

RESULTS

Patients had a median age of 38 (interquartile range 25, 58) years, ISS of 19 (13, 29), and mortality of 7%. Seventy-eight percent were men, and 84% had blunt trauma. Patients received a median of 6 (4, 16) (range 2, 87) units of PRBCs. Of the 45 patients, 24 (53%) had evidence of microchimerism. Compared with patients without evidence of microchimerism, these patients had no difference in mean age, gender, ISS, units of PRBCs transfused, time from transfusion to blood sampling, or proportion that underwent splenectomy. Twenty-one of the 24 patients with microchimerism had only 1 or 2 non-recipient DR alleles identified by PCR.

CONCLUSIONS

Transfusion after trauma is associated with over half of recipients having evidence of microchimerism. Age, sex, ISS, and splenectomy of the recipient and the number of transfused units did not correlate with microchimerism. Because the median time from transfusion to sampling for PCR analysis was not longer in the group without microchimerism, it is unlikely microchimerism is due merely to failure of the recipient to clear transfused donor leukocytes.

摘要

引言

输血可导致供体白细胞亚群在受者体内存活。供体白细胞在输血受者体内持续存在被称为微嵌合体。微嵌合体可能反映了受者被供体造血干细胞植入,在择期手术、镰状细胞贫血、地中海贫血和艾滋病病毒感染输血中非常罕见。然而,我们发现微嵌合体在创伤患者中可能更常见。

目的

确定创伤后输血与微嵌合体相关的频率。

方法

我们前瞻性纳入了45例输注≥2单位浓缩红细胞的创伤患者。在出院前采集血液样本,通过聚合酶链反应(PCR)分析标本,使用定量等位基因特异性HLA DR检测来检测非受者等位基因,以确定微嵌合体。数据以中位数和四分位数间距表示。

结果

患者的中位年龄为38岁(四分位数间距25, 58),损伤严重程度评分(ISS)为19(13, 29),死亡率为7%。78%为男性,84%为钝性创伤。患者接受的浓缩红细胞单位中位数为6(4, 16)(范围2, 87)。45例患者中,24例(53%)有微嵌合体证据。与无微嵌合体证据的患者相比,这些患者在平均年龄、性别、ISS、输注的浓缩红细胞单位数、从输血到采血的时间或接受脾切除术的比例方面无差异。24例有微嵌合体的患者中,21例通过PCR仅鉴定出1个或2个非受者DR等位基因。

结论

创伤后输血与超过一半的受者有微嵌合体证据相关。受者的年龄、性别、ISS和脾切除术以及输注单位数与微嵌合体无关。由于无微嵌合体组从输血到PCR分析采样的中位时间并不长,微嵌合体不太可能仅仅是由于受者未能清除输注的供体白细胞所致。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验